Fumagillin-Derived Polymer Conjugate XMT-1107

A polymeric prodrug consisting of the fumagillol-derived small molecule XMT-1191 tethered to the hydrophilic, biodegradable70 kDa polymer poly[1-hydroxymethylethylene hydroxymethylformal] (PHF) with potential antiangiogenic and antineoplastic activities. Upon administration, fumagillin-derived polymer conjugate XMT-1107 releases XMT-1191, which may inhibit angiogenesis through the irreversible inhibition of the methionine aminopeptidase 2 (METAP2); although the exact mechanism of action has yet to be fully elucidated, this agent appears to induce cell cycle arrest in endothelial cells, inhibiting their proliferation and migration. Compared to an unconjugated fumagillin analog, XMT-1107 exhibits improved solubility and an extended half life due to its PHF backbone. METAP2, a member of the methionyl aminopeptidase family, binds two cobalt or manganese ions and protects the alpha subunit of eukaryotic initiation factor 2 (EIF2) from inhibitory phosphorylation by removing the amino-terminal methionine residue from nascent protein; this aminopeptidase may be overexpressed in a variety of tumor cell types. (NCI Thesaurus)

YOU MAY ALSO LIKE

Fulvestrant

A drug used to treat certain types of breast cancer in postmenopausal women. It is also being studied in the treatment of…

Fulranumab

A fully human monoclonal antibody directed against nerve growth factor (NGF) with potential analgesic activity. Upon administration, fulranumab binds to NGF, preventing…

Fullerene

Source: National Cancer Institute (U.S.)

Full Width at Half Maximum

A measure of resolution used when a system's response y (such as image-displayed activity concentration) to an ideal infinitely narrow spatially distributed…

Full Time Employment

Employed for a standard number of hours of working time, at least 50% or 20 hours per week

Full Term Neonate

An infant born after completion of the normal gestational period.